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Abstract 
The conjugation of antigens with ligands of pattern recognition receptors (PRR) is 
emerging as a promising strategy for the modulation of specific immunity. Here, we 
describe a new Escherichia coli system for the cloning and expression of heterologous 
antigens in fusion with the OprI lipoprotein, a TLR ligand from the Pseudomonas 
aeruginosa outer membrane (OM). Analysis of the OprI expressed by this system 
reveals a triacylated lipid moiety mainly composed by palmitic acid residues. By 
offering a tight regulation of expression and allowing for antigen purification by metal 
affinity chromatography, the new system circumvents the major drawbacks of former 
versions. In addition, the anchoring of OprI to the OM of the host cell is further 
explored for the production of novel recombinant bacterial cell wall-derived 
formulations (OM fragments and OM vesicles) with distinct potential for PRR 
activation. As an example, the African swine fever virus ORF A104R was cloned and the 
recombinant antigen was obtained in the three formulations. Overall, our results 
validate a new system suitable for the production of immunogenic formulations that 
can be used for the development of experimental vaccines and for studies on the 
modulation of acquired immunity. 
 
Highlights 
► We propose a new system for expression of antigens fused with the OprI 
lipoprotein. ► It offers tight control of expression and metal affinity chromatography 
purification. ► The OprI expressed by the system is triacylated, mainly by palmitic acid 
residues. ► The cloned antigens can be obtained in three bacterial cell wall-derived 
formulations. ► Applications include studies on immunization and on modulation of 
acquired immunity. 
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